United States (US) Sepsis Therapeutics Market (2025-2031) | Share, Trends, Outlook, Value, Forecast, Analysis, Competitive Landscape, Industry, Segmentation, Growth, Companies, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Sepsis Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Sepsis Therapeutics Market - Industry Life Cycle

3.4 United States (US) Sepsis Therapeutics Market - Porter's Five Forces

3.5 United States (US) Sepsis Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Sepsis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 United States (US) Sepsis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing awareness about sepsis and its complications among healthcare professionals and patients

4.2.2 Increasing prevalence of sepsis cases in the United States

4.2.3 Technological advancements in sepsis diagnostics and treatment options

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval of new sepsis therapeutics

4.3.2 High cost associated with sepsis treatment and management

4.3.3 Limited availability of effective therapies for sepsis

6.1 United States (US) Sepsis Therapeutics Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Aminoglycosides, 2021- 2031F

6.1.4 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Cephalosporin, 2021- 2031F

6.1.5 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Glycopeptide Antibiotics, 2021- 2031F

6.1.6 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Sepsis Therapeutics Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.3 United States (US) Sepsis Therapeutics Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 United States (US) Sepsis Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7.1 United States (US) Sepsis Therapeutics Market Export to Major Countries

7.2 United States (US) Sepsis Therapeutics Market Imports from Major Countries

8.1 Survival rate of sepsis patients

8.2 Adoption rate of innovative sepsis therapeutics

8.3 Rate of hospital readmissions for sepsis patients

9.1 United States (US) Sepsis Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Sepsis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 United States (US) Sepsis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United States (US) Sepsis Therapeutics Market Revenue Share, By Companies, 2024

10.2 United States (US) Sepsis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters